These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28413042)

  • 21. The sexuological impact of hormonal contraceptives based on their route of administration.
    Guida M; Di Carlo C; Troisi J; Gallo A; Cibarelli F; Martini E; Tiranini L; Nappi RE
    Gynecol Endocrinol; 2017 Mar; 33(3):218-222. PubMed ID: 27908210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health outcomes associated with use of hormonal contraception: breast cancer.
    Schneyer R; Lerma K
    Curr Opin Obstet Gynecol; 2018 Dec; 30(6):414-418. PubMed ID: 30239373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
    Truitt ST; Fraser AB; Grimes DA; Gallo MF; Schulz KF
    Cochrane Database Syst Rev; 2003; (2):CD003988. PubMed ID: 12804497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal contraception.
    Shearin RB; Boehlke JR
    Pediatr Clin North Am; 1989 Jun; 36(3):697-715. PubMed ID: 2660092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why Stop Now? Extended and Continuous Regimens of Combined Hormonal Contraceptive Methods.
    Benson LS; Micks EA
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):669-81. PubMed ID: 26598308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal contraception and lactation.
    Kelsey JJ
    J Hum Lact; 1996 Dec; 12(4):315-8. PubMed ID: 9025449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
    Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
    Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM).
    Both S; Lew-Starowicz M; Luria M; Sartorius G; Maseroli E; Tripodi F; Lowenstein L; Nappi RE; Corona G; Reisman Y; Vignozzi L
    J Sex Med; 2019 Nov; 16(11):1681-1695. PubMed ID: 31521571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
    Corson SL
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The CHOICE study (Contraceptive Health Research Of Informed Choice Experience)--an educational research program for Polish women planning combined hormonal contraceptives use].
    Tomaszewski J; Paszkowski T; Debski R; Kotarski J; Skrzypulec-Plinta V; Spaczyński RZ; Pawelczyk L
    Ginekol Pol; 2012 Jun; 83(6):417-23. PubMed ID: 22880460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal contraceptives for contraception in overweight or obese women.
    Lopez LM; Grimes DA; Chen M; Otterness C; Westhoff C; Edelman A; Helmerhorst FM
    Cochrane Database Syst Rev; 2013 Apr; (4):CD008452. PubMed ID: 23633356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined hormonal contraception and migraine: are we being too strict?
    Voedisch AJ; Hindiyeh N
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):452-458. PubMed ID: 31573998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
    Kurvits K; Laius O; Uusküla M; Laanpere M
    Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):413-420. PubMed ID: 34160334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003989. PubMed ID: 18843653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestin-only oral contraception: a comprehensive review.
    McCann MF; Potter LS
    Contraception; 1994 Dec; 50(6 Suppl 1):S1-195. PubMed ID: 10226677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
    Belsey EM
    Contraception; 1988 Aug; 38(2):207-25. PubMed ID: 2971506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined hormonal contraception in cycles artificially extended].
    Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
    Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal contraception, thrombosis and age.
    Lidegaard Ø
    Expert Opin Drug Saf; 2014 Oct; 13(10):1353-60. PubMed ID: 25227335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.